newsfilter
← Latest News
GlobeNewswire·

Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights

- Appointed Michael Halstead, former President of Intra-Cellular Therapies, as Chief Executive Officer to lead Helus Pharma through late-stage development and commercialization - - Completed enrollment in the Phase 3